Amylx Pharmaceuticals Inc vs Kaltura Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Kaltura Inc trades at $1.61 (market cap $249.42M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 10.6× Kaltura Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Kaltura Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | KLTR | |
|---|---|---|
Market Cap | $2.64B | $249.42M |
Sector | Health | Technology |
52-Week High | $24.19 | $1.89 |
52-Week Low | $7.82 | $1.08 |
Enterprise Value | $2.39B | $261.64M |
Trailing returns across standard periods
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →